156 related articles for article (PubMed ID: 33215418)
1. Knockdown of lncRNA HCG11 suppresses cell progression in ovarian cancer by modulating miR-144-3p/PBX3.
Li XF; Hu DM; Zhao YX; Zhang L; Jin Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11032-11040. PubMed ID: 33215418
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA HCG11 sponging miR-522-3p inhibits the tumorigenesis of non-small cell lung cancer by upregulating SOCS5.
Fan G; Jiao J; Shen F; Ren Q; Wang Q; Chu F
Thorac Cancer; 2020 Oct; 11(10):2877-2886. PubMed ID: 32844573
[TBL] [Abstract][Full Text] [Related]
5. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p.
Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y
J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3.
Wang D; You D; Pan Y; Liu P
Thorac Cancer; 2020 Jul; 11(7):1963-1971. PubMed ID: 32449803
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
Xu J; Xu W; Yang X; Liu Z; Sun Q
Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
[TBL] [Abstract][Full Text] [Related]
10. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HCG11 Accelerates Atherosclerosis via Regulating the miR-224-3p/JAK1 Axis.
Zhou H; Song WH
Biochem Genet; 2023 Feb; 61(1):372-389. PubMed ID: 35931919
[TBL] [Abstract][Full Text] [Related]
12. MiR-655-3p inhibits growth and invasiveness of trophoblasts via targeting PBX3 and thus deteriorates preeclampsia.
Song H; Wang X; Li JC; Lv YH
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10346-10351. PubMed ID: 33155190
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
Cui Z; Wang Q; Deng MH; Han QL
Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
[TBL] [Abstract][Full Text] [Related]
15. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
Xu H; Mao HL; Zhao XR; Li Y; Liu PS
J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA HCG11 Inhibits Glioma Cells Proliferation and Migration through Decoying miR-590-3p and Up-Regulating CADM2.
Jinyang M; Bojuan L; Lixin X; Wan D; Sun T
Pathobiology; 2022; 89(4):233-244. PubMed ID: 35279660
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HCG11 Inhibits Adipocyte Differentiation in Human Adipose-Derived Mesenchymal Stem Cells by Sponging miR-204-5p to Upregulate SIRT1.
Li D; Liu Y; Gao W; Han J; Yuan R; Zhang M; Ge Z
Cell Transplant; 2020; 29():963689720968090. PubMed ID: 33086891
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HCG11 suppresses laryngeal carcinoma cells progression via sponging miR-4469/APOM axis.
Xue HX; Li HF; Wang T; Li WJ; Bian WC
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3174-3182. PubMed ID: 32271435
[TBL] [Abstract][Full Text] [Related]
19. MiR-320 inhibits the growth of glioma cells through downregulating PBX3.
Pan C; Gao H; Zheng N; Gao Q; Si Y; Zhao Y
Biol Res; 2017 Sep; 50(1):31. PubMed ID: 28934982
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HCG11 Suppresses Cell Proliferation and Promotes Apoptosis via Sponging miR-224-3p in Non-Small-Cell Lung Cancer Cells.
Wang G; Liu L; Zhang J; Huang C; Chen Y; Bai W; Wang Y; Zhao K; Li S
Onco Targets Ther; 2020; 13():6553-6563. PubMed ID: 32694917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
